Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ) *
Aimei Health Technology Co., Ltd.
(Name of Issuer)
Common
(Title of Class of Securities)
G01341109
(CUSIP Number)
March 28, 2024
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒ Rule 13d-1(b)
☐ Rule 13d-1(c)
☐ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. G01341109 |
13G | Page 2 of 5 Pages |
1. | NAME OF REPORTING PERSON(S)
Karpus Investment Management
|
|||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐ (b) ☒ | ||
3. | SEC USE ONLY
|
|||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
New York
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. |
SOLE VOTING POWER
1,100,657 Shares
| ||
6. | SHARED VOTING POWER
0 Shares
| |||
7. | SOLE DISPOSITIVE POWER
1,100,657 Shares
| |||
8. | SHARED DISPOSITIVE POWER
0 Shares
|
9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,100,657 Shares
|
|||
10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
☐ | ||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.19%
|
|||
12. |
TYPE OF REPORTING PERSON
IA
|
CUSIP No. G01341109 |
13G | Page 3 of 5 Pages |
Item 1(a). | Name of Issuer: |
Aimei Health Technology Co., Ltd.
Item 1(b). | Address of Issuer's Principal Executive Offices: |
10 East 53rd Street, Suite 3001, New York, NY 10022
Item 2(a). | Name of Person Filing: |
This statement is being filed by Karpus Management, Inc., d/b/a Karpus Investment Management (“Karpus” or the “Reporting Person”). Karpus is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940. Karpus is controlled by City of London Investment Group plc (“CLIG”), which is listed on the London Stock Exchange. However, in accordance with SEC Release No. 34-39538 (January 12, 1998), effective informational barriers have been established between Karpus and CLIG such that voting and investment power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly, attribution of beneficial ownership is not required between Karpus and CLIG.
The Shares to which this Schedule 13G relates are owned directly by the accounts managed by Karpus.
Item 2(b). | Address of Principal Business Office or, if none, Residence: |
183 Sully's Trail, Pittsford, New York 14534.
Item 2(c). | Citizenship: |
The members of the Karpus Management Committee are US citizens. Karpus is a New York corporation.
Item 2(d). | Title of Class of Securities. |
Common
Item 2(e). | CUSIP Number. |
G01341109
Item 3. | If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) | ☐ | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); |